Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04657068
Title A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Artios Pharma Ltd
Indications

fallopian tube carcinoma

Advanced Solid Tumor

peritoneal carcinoma

ovarian serous carcinoma

Therapies

ART0380 + Gemcitabine

ART0380

Gemcitabine

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE Recruiting Denver Colorado 80218 United States Details
Florida Cancer Specialists Recruiting Fort Myers Florida 33901 United States Details
Florida Cancer Specialists Recruiting Orlando Florida 32827 United States Details
Florida Cancer Specialists Recruiting Sarasota Florida 34232 United States Details
Florida Cancer Specialists Recruiting West Palm Beach Florida 33401 United States Details
Stephenson Cancer Center Recruiting Oklahoma City Oklahoma 73104 United States Details
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization Recruiting Philadelphia Pennsylvania 19107 United States Details
Tennessee Oncology, PLLC Recruiting Chattanooga Tennessee 37404 United States Details
Tennessee Oncology Recruiting Nashville Tennessee 37203 United States Details
Sarah Cannon Research Institute UK Recruiting London W1G 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field